Matinas BioPharma
MTNB
MTNB
50 hedge funds and large institutions have $21.5M invested in Matinas BioPharma in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 11 closing their positions.
Holders
50
Holders Change
-6
Holders Change %
-10.71%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
8
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
NRS
1
Neville Rodie & Shaw
New York
|
$1.39M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$6.65M |
3 |
SIG
3
Sargent Investment Group
Bethesda,
Maryland
|
$3.13M |
4 |
4
Jane Street
New York
|
$129K |
5 |
VF
5
Virtu Financial
New York
|
$73K |